ROCHE PRODUCTS LIMITED
Get an alert when ROCHE PRODUCTS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-05-13 (in 1y)
Last made up 2026-04-29
Watchouts
None on the register
Cash
—
Latest balance sheet
Net assets
£335M
+6.9% vs 2023
Employees
1,417
-5.8% vs 2023
Profit before tax
£47M
-9.6% vs 2023
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £1,141,771,000 | £1,201,116,000 | |
| Operating profit | £35,792,000 | £35,698,000 | |
| Profit before tax | £51,842,000 | £46,854,000 | |
| Net profit | £36,363,000 | £31,292,000 | |
| Cash | £161,182,000 | — | |
| Total assets less current liabilities | £327,647,000 | £356,263,000 | |
| Net assets | £313,902,000 | £335,439,000 | |
| Equity | £313,902,000 | £335,439,000 | |
| Average employees | 1,505 | 1,417 | |
| Wages | £149,836,000 | £169,903,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 3.1% | 3.0% | |
| Net margin | 3.2% | 2.6% | |
| Return on capital employed | 10.9% | 10.0% | |
| Gearing (liabilities / total assets) | 55.7% | 52.9% | |
| Current ratio | 1.21x | 1.28x | |
| Interest cover | 86.25x | 18.24x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have prepared the financial statements on the going concern basis as they do not intend to liquidate the Company or to cease its operations, and as they have concluded that the Company's financial position means that this is realistic. They have also concluded that there are no material uncertainties that could have cast significant doubt over its ability to continue as a going concern for at least a year from the date of approval of the financial statements ("the going concern period").”
Group structure
- ROCHE PRODUCTS LIMITED · parent
- Roche Products (Ireland) Limited 100%
- Nicholas Laboratories Limited 100%
- Roche Products Pension Trust Limited 100%
- Roche Healthcare Trustee Limited 100%
Significant events
- “In 2024 the product sales volume of the Company increased mostly due to our strategic product, Vabysmo, resulting in an overall increase of 18.8% to £866 million (2023: £729million).”
- “The Company entered the 2024 scheme (effective 1 January 2024 to 31 December 2028) and also participated in the 2019 scheme (effective 1 January 2019 to 31 December 2023. The Company will continue to adopt the necessary changes to pricing of products to ensure compliance with the scheme.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
6 active · 41 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| DAVIS, Scott | Secretary | 2019-03-13 | — | — |
| DAVIS, Scott | Director | 2025-01-27 | Nov 1970 | British |
| FERRARO, Robert | Director | 2022-07-11 | Jun 1970 | Swiss |
| LOEWENSTEIN, Danielle Lisa | Director | 2025-01-27 | Feb 1984 | Israeli |
| PAMBA, Allan, Dr | Director | 2026-04-21 | Aug 1971 | British,Kenyan |
| ROWBOTHAM, Kathryn | Director | 2025-08-11 | Aug 1976 | American |
Show 41 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ABIMBOLA, Olufunke | Secretary | 2015-06-22 | 2018-07-06 |
| BAILEY, Derek John | Secretary | — | 1993-04-30 |
| DANIEL, Richard David | Secretary | 1994-07-16 | 2015-06-22 |
| ROBERTSON, Mandy Elizabeth | Secretary | 2018-07-09 | 2019-03-12 |
| ACKERMANN, Vic | Director | 1997-10-24 | 2000-06-14 |
| BELL, Gavin Keith | Director | 1995-03-10 | 1999-03-09 |
| BRABECK LETMATHE, Andreas | Director | 2004-01-09 | 2012-08-31 |
| CLOUGH, David Peter | Director | — | 1999-03-09 |
| CUMA, Benan | Director | 2020-11-01 | 2024-07-31 |
| DALLAS, Jayson Donald Alexander | Director | 2013-01-01 | 2015-07-24 |
| DAVIES, James Lyndon, Dr | Director | — | 1999-03-09 |
| ERWIN, Richard William | Director | 2015-09-01 | 2025-07-03 |
| GOLDSMITH, John Anthony, Professor | Director | — | 1991-09-20 |
| GRANT, Alexander | Director | 1999-03-09 | 2004-03-30 |
| GRIFFITHS, David | Director | — | 1994-07-16 |
| HOLLADAY, Nicol Adrian | Director | 1994-10-14 | 1997-10-24 |
| HORNIBROOK, John Nevill | Director | — | 1993-04-30 |
| HUMER, Franz Bernhard | Director | 1995-06-16 | 1999-03-09 |
| JACKSON, David James | Director | 1994-07-16 | 2001-09-30 |
| KELLY, Timothy Edwin | Director | 2017-03-01 | 2018-12-31 |
| KESSLER, Armin Maximilian, Dr | Director | — | 1995-06-16 |
| KRAEHENMANN, Beat Christoph | Director | 2014-03-05 | 2022-07-11 |
| LENNERTZ, James Karin Jnr | Director | 2002-01-14 | 2004-01-09 |
| LEUBERGER, Andres Friedrich, Doctor | Director | — | 1999-03-09 |
| MCCLYMONT, Thomas Mcdonald, Doctor | Director | 1993-04-27 | 1997-02-21 |
| MELVILLE, John Mcmillan | Director | 2000-06-14 | 2012-12-31 |
| NEWTON-SYMS, Paul Anthony | Director | — | 1992-10-02 |
| PARKER, Christopher Stuart | Director | 2012-08-07 | 2017-07-01 |
| RACKLEY, John Phillip | Director | 1995-03-10 | 1999-03-09 |
| SCHILKE, Tobin Charles | Director | 2014-08-04 | 2016-06-10 |
| SCHUMACHER, Christiane | Director | 2016-06-10 | 2017-03-01 |
| SOAMES, Arthur Nicholas Winston, Hon | Director | — | 1992-04-15 |
| STONE, Kenneth John, Dr | Director | 1992-10-02 | 1994-10-14 |
| SUMMERFIELD, Peter John Frederick, Doctor | Director | — | 1991-12-31 |
| TAYLOR, Kenneth Martin, Dr | Director | — | 1994-12-16 |
| TWIST, Geoffrey John | Director | 2017-10-01 | 2026-02-05 |
| VAN DEN BOER, Jan | Director | 2004-07-22 | 2012-08-07 |
| VITUG, Kezia Jayn | Director | 2019-03-01 | 2020-10-31 |
| WILLIAMS, Mark Lloyd | Director | 2012-08-31 | 2014-05-30 |
| WILLIAMSON, Basil, Doctor | Director | 1997-02-21 | 1999-03-09 |
| WRIGHT, Richard John | Director | 2015-07-24 | 2015-09-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Roche Holding (Uk) Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-06-01 | Active |
Filing timeline
Last 20 of 206 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-29 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-04-29 | AP01 | officers | Appoint person director company with name date | |
| 2026-02-06 | TM01 | officers | Termination director company with name termination date | |
| 2025-10-23 | AA | accounts | Accounts with accounts type full | |
| 2025-08-19 | AP01 | officers | Appoint person director company with name date | |
| 2025-07-23 | TM01 | officers | Termination director company with name termination date | |
| 2025-05-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-04-24 | CH01 | officers | Change person director company with change date | |
| 2025-02-03 | AP01 | officers | Appoint person director company with name date | |
| 2025-02-03 | AP01 | officers | Appoint person director company with name date | |
| 2024-09-27 | AAMD | accounts | Accounts amended with accounts type full | |
| 2024-08-05 | TM01 | officers | Termination director company with name termination date | |
| 2024-07-22 | AA | accounts | Accounts with accounts type full | |
| 2024-05-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-09-15 | AA | accounts | Accounts with accounts type full | |
| 2023-05-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-07-11 | TM01 | officers | Termination director company with name termination date | |
| 2022-07-11 | AP01 | officers | Appoint person director company with name date | |
| 2022-06-28 | AA | accounts | Accounts with accounts type full | |
| 2022-05-26 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 7
- Capital events
- 0
- Officers appointed
- 2
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+5.2%
£1,141,771,000 £1,201,116,000
-
Cash
—
Not reported
-
Net assets
+6.9%
£313,902,000 £335,439,000
-
Employees
-5.8%
1,505 1,417
-
Operating profit
-0.3%
£35,792,000 £35,698,000
-
Profit before tax
-9.6%
£51,842,000 £46,854,000
-
Wages
+13.4%
£149,836,000 £169,903,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers